Loading...
Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma
BACKGROUND: Large randomised clinical trials and systematic reviews substantiate that tamoxifen is ineffective in improving survival of patients with hepatocellular carcinoma (HCC). However, a recent report suggested that the drug might prolong survival among patients with well preserved liver funct...
Na minha lista:
Main Authors: | , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
BioMed Central
2006
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1555599/ https://ncbi.nlm.nih.gov/pubmed/16863588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-6-196 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|